4.8 Article

Antiviral Nanobiologic Therapy Remodulates Innate Immune Responses to Highly Pathogenic Coronavirus

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Immunology

SARS-CoV-2 treatment effects induced by ACE2-expressing microparticles are explained by the oxidized cholesterol-increased endosomal pH of alveolar macrophages

Zhenfeng Wang et al.

Summary: The study demonstrates the potential therapeutic effect of ACE2-overexpressing A549 cell-derived microparticles (AO-MPs) against SARS-CoV-2 infection by changing endosomal pH and promoting viral degradation. In addition to inhibiting the inflammatory response of alveolar macrophages, AO-MPs increase treatment efficacy in a SARS-CoV-2-infected mouse model without side effects, highlighting the potential use of AO-MPs in treating SARS-CoV-2-infected patients and the feasibility of microparticle therapies for combating emerging respiratory viruses in the future.

CELLULAR & MOLECULAR IMMUNOLOGY (2022)

Article Virology

Resolution of viral load in mild COVID-19 patients is associated with both innate and adaptive immune responses

Anbalagan Anantharaj et al.

Summary: Over 90% of COVID-19 patients exhibit mild/moderate symptoms or are asymptomatic. This study collected samples from 23 hospitalized patients with mild symptoms and found that most mild infections are associated with an absence of inflammation and an active innate immune response, T-cell activation, and neutralizing antibodies.

JOURNAL OF CLINICAL VIROLOGY (2022)

Review Immunology

The cholesterol pathway: impact on immunity and cancer

Ryan J. King et al.

Summary: Cholesterol plays a role in cancer, atherosclerosis, and autoimmunity by modulating the immune system. Manipulating cholesterol metabolism may improve immunotherapy responses in cancer treatment. It can have both proinflammatory and anti-inflammatory effects in mammals, acting through various immune cell types depending on the context. Understanding the mechanisms of cholesterol-related metabolites can enhance our knowledge of their functions and effects on the immune system, leading to the development of better therapeutic strategies.

TRENDS IN IMMUNOLOGY (2022)

Article Multidisciplinary Sciences

Spike mutation D614G alters SARS-CoV-2 fitness

Jessica A. Plante et al.

Summary: The D614G substitution in the SARS-CoV-2 spike protein enhances viral replication and infectivity in human lung epithelial cells, primary airway tissues, and hamsters. This variant may increase transmission in the upper respiratory tract and doesn't seem to significantly reduce vaccine efficacy. Further research on therapeutic antibodies targeting the circulating G614 virus is recommended.

NATURE (2021)

Review Immunology

Combining Antivirals and Immunomodulators to Fight COVID-19

Vincent Feuillet et al.

Summary: Most individuals infected with SARS-CoV-2 have mild symptoms, possibly due to their ability to rapidly produce interferons, while a minority of infected individuals with chronic inflammatory conditions lack this early efficient response.

TRENDS IN IMMUNOLOGY (2021)

Article Chemistry, Physical

Virus-Free and Live-Cell Visualizing SARS-CoV-2 Cell Entry for Studies of Neutralizing Antibodies and Compound Inhibitors

Yali Zhang et al.

Summary: The study describes the development of a genetically engineered sensor, STG, that can effectively visualize the cellular entry process of SARS-CoV-2. The system allows for quantitative analysis of inhibition potentials and can be used for screening and characterizing SARS-CoV-2 entry inhibitors. This approach has the potential for adaptation to develop similar systems for visualizing viral entry of other viruses.

SMALL METHODS (2021)

Review Chemistry, Multidisciplinary

Tailoring Materials for Modulation of Macrophage Fate

Jinhua Li et al.

Summary: This review focuses on the design strategies and principles of immunomodulatory biomaterials to regulate macrophage fate, as well as their potential applications in various immunengineering fields. The tunability of material designs, including physical, chemical, biological, and dynamic cues, plays a crucial role in modulating macrophage immune response. The selected immunoengineering applications demonstrate how macrophage-immunomodulating biomaterials are being utilized for cancer immunotherapy, infection immunotherapy, tissue regeneration, inflammation resolution, and vaccination.

ADVANCED MATERIALS (2021)

Article Chemistry, Multidisciplinary

Surface Glycan Modification of Cellular Nanosponges to Promote SARS-CoV-2 Inhibition

Xiangzhao Ai et al.

Summary: Increasing surface heparin density on cellular nanosponges can enhance their inhibition against SARS-CoV-2, providing a facile approach to boost antiviral efficacy by mimicking host cells and utilizing glycan engineering strategies.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2021)

Article Chemistry, Multidisciplinary

Nanotechnology for virus treatment

Jiarong Zhou et al.

Summary: The emergence of novel viruses poses a significant threat to global health, with nanotechnology offering potential solutions to overcome challenges in antiviral therapies. Nanotechnology can improve drug absorption and reduce toxicity, as well as utilize unique nanomaterials for virus inactivation. By researching the latest developments in antiviral nanotherapeutics, new solutions can be provided for future virus pandemics.

NANO TODAY (2021)

Article Multidisciplinary Sciences

SARS-CoV-2 spike D614G change enhances replication and transmission

Bin Zhou et al.

Summary: Research has shown that the D614G substitution in the spike protein of SARS-CoV-2 leads to increased binding and replication potential in humans, as well as significantly higher replication and transmissibility in different animal models, providing an explanation for the global prevalence of this variant in the COVID-19 pandemic.

NATURE (2021)

Article Multidisciplinary Sciences

Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7

Pengfei Wang et al.

Summary: The COVID-19 pandemic has had global repercussions, with promising vaccines and monoclonal antibody therapies. However, newly detected variants of SARS-CoV-2 present challenges to these treatment options.

NATURE (2021)

Article Multidisciplinary Sciences

The prevalence of antibodies to SARS-CoV-2 among blood donors in China

Le Chang et al.

Summary: The study investigated the seroprevalence of SARS-CoV-2 antibodies among blood donors in Wuhan, Shenzhen, and Shijiazhuang in China. The highest age- and sex-standardized SARS-CoV-2 seroprevalence of 2.66% was found among 18-60 year-old adults in Wuhan.

NATURE COMMUNICATIONS (2021)

Review Microbiology

Innate immune and inflammatory responses to SARS-CoV-2: Implications for COVID-19

Shea A. Lowery et al.

Summary: Severe disease from COVID-19 is characterized by significant immunopathology driven by unbalanced innate immune response with limited and delayed interferon response, leading to excessive proinflammatory cytokine production and cellular infiltrates in the respiratory tract causing lung pathology. Effective therapeutics for severe COVID-19 patients depend on understanding the pathological elements of this dysregulated innate immune response, as well as identifying therapeutic strategies targeting these elements of the innate response.

CELL HOST & MICROBE (2021)

Article Infectious Diseases

Early control of viral load by favipiravir promotes survival to Ebola virus challenge and prevents cytokine storm in non-human primates

Stephanie Reynard et al.

Summary: Ebola virus has caused major epidemics in Central and West African countries in recent years. Studies have shown that reducing viral load through antiviral treatment can prevent detrimental immune responses and pathogenic events seen in Ebola virus disease. Management of viral replication is crucial in preventing immunopathogenic disorders and septic-like shock syndrome in Ebola virus-infected patients.

PLOS NEGLECTED TROPICAL DISEASES (2021)

Article Nanoscience & Nanotechnology

Cell-mimicking nanodecoys neutralize SARS-CoV-2 and mitigate lung injury in a non-human primate model of COVID-19

Zhenhua Li et al.

Summary: The authors demonstrate that nanovesicles coated with lung spheroid cell membranes expressing angiotensin-converting enzyme 2 can bind and neutralize SARS-CoV-2, potentially serving as a therapeutic agent for treating COVID-19.

NATURE NANOTECHNOLOGY (2021)

Article Multidisciplinary Sciences

Inhalable nanocatchers for SARS-CoV-2 inhibition

Han Zhang et al.

Summary: Amid the global COVID-19 pandemic caused by SARS-CoV2, scientists have developed a novel approach to combat the virus, by designing hACE2-containing nanocatchers to protect cells from infection and potentially provide an alternative treatment option. This innovative method shows promising results in inhibiting SARS-CoV-2 infections, including mutated strains, and offers great potential for future clinical use in the ongoing epidemic.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

Article Immunology

SARS-CoV-2 membrane glycoprotein M antagonizes the MAVS-mediated innate antiviral response

Yu-Zhi Fu et al.

Summary: A novel SARS-related coronavirus (SARS-CoV-2) has emerged as a serious pathogen causing high morbidity and mortality. The membrane glycoprotein M of SARS-CoV-2 was identified as a negative regulator of the innate immune response by impairing MAVS aggregation and downstream signaling, thus evading the innate antiviral response.

CELLULAR & MOLECULAR IMMUNOLOGY (2021)

Article Biochemistry & Molecular Biology

Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19

Daniel Blanco-Melo et al.

Editorial Material Biology

Cell membrane-derived biomimetic nanodecoys for viruses

Liu Xuan et al.

SCIENCE CHINA-LIFE SCIENCES (2020)

Article Biochemistry & Molecular Biology

SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2

Thomas Mandel Clausen et al.

Article Multidisciplinary Sciences

Decoy nanoparticles protect against COVID-19 by concurrently adsorbing viruses and inflammatory cytokines

Lang Rao et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

Article Multidisciplinary Sciences

Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms

M. Alejandra Tortorici et al.

SCIENCE (2020)

Article Cell Biology

Evasion of Type I Interferon by SARS-CoV-2

Hongjie Xia et al.

CELL REPORTS (2020)

Review Immunology

On the genetics and immunopathogenesis of COVID-19

Chaim Oscar Jacob

CLINICAL IMMUNOLOGY (2020)

Article Biochemistry & Molecular Biology

SARS-CoV-2 evades immune detection in alveolar macrophages

Louise Dalskov et al.

EMBO REPORTS (2020)

Article Immunology

SARS-CoV-2 nsp13, nsp14, nsp15 and orf6 function as potent interferon antagonists

Chun-Kit Yuen et al.

EMERGING MICROBES & INFECTIONS (2020)

Article Medicine, Research & Experimental

IFN-I response timing relative to virus replication determines MERS coronavirus infection outcomes

Rudragouda Channappanavar et al.

JOURNAL OF CLINICAL INVESTIGATION (2019)

Article Chemistry, Multidisciplinary

T-Cell-Mimicking Nanoparticles Can Neutralize HIV Infectivity

Xiaoli Wei et al.

ADVANCED MATERIALS (2018)

Article Chemistry, Multidisciplinary

Bioinspired Artificial Nanodecoys for Hepatitis B Virus

Xuan Liu et al.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2018)

Article Gastroenterology & Hepatology

Viral Load Affects the Immune Response to HBV in Mice With Humanized Immune System and Liver

Mathilde Dusseaux et al.

GASTROENTEROLOGY (2017)

Review Biotechnology & Applied Microbiology

Inhibiting host-pathogen interactions using membrane-based nanostructures

Daniel A. Bricarello et al.

TRENDS IN BIOTECHNOLOGY (2012)

Article Virology

SARS coronavirus pathogenesis: host innate immune responses and viral antagonism of interferon

Allison L. Totura et al.

CURRENT OPINION IN VIROLOGY (2012)

Review Microbiology

Coronaviruses post-SARS: update on replication and pathogenesis

Stanley Perlman et al.

NATURE REVIEWS MICROBIOLOGY (2009)